Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide <i>in vitro</i> and in a mouse model

Meenakshi Malhotra(Natera (United States)), Tarik F. Massoud(Palo Alto University)
Oncotarget
April 20, 2018
Cited by 70


Related Papers